Maternal IgG Anti-A and Anti-B Titer Levels Screening in Predicting ABO Hemolytic Disease of the Newborn: A Meta-Analysis
Authors:
- 11 September 2015
- journal article
- research article
- Published by Taylor & Francis in Fetal and Pediatric Pathology
- Vol. 34 (6) , 341-350
Abstract
(2015). Maternal IgG Anti-A and Anti-B Titer Levels Screening in Predicting ABO Hemolytic Disease of the Newborn: A Meta-Analysis. Fetal and Pediatric Pathology: Vol. 34, No. 6, pp. 341-350. doi: 10.3109/15513815.2015.1075632Keywords
This publication has 20 references indexed in Scilit:
- Maternal IgG anti‐A and anti‐B titres predict outcome in ABO‐incompatibility in the neonateActa Paediatrica, 2009
- Correlation of FcγRIIa (CD32) Polymorphism and IgG Antibody Subclasses in Hemolytic Disease of NewbornNeonatology, 2009
- Haemolytic disease of the newborn: Table 1Archives of Disease in Childhood - Fetal and Neonatal Edition, 2007
- Hemolytic disease of the newborn caused by a high titer anti-group B IgG from a group A motherPediatric Blood & Cancer, 2005
- ABO incompatibility due to immunoglobulin G anti‐B antibodies presenting with severe fetal anaemiaTransfusion Medicine, 2005
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Red cell antibodies in pregnancy: there is no ‘critical titre’Transfusion Medicine, 1995
- WHAT IS THE BEST PREDICTOR OF THE SEVERITY OF ABO-HAEMOLYTIC DISEASE OF THE NEWBORN?The Lancet, 1988
- Risk of neonatal hyperbilirubinemia in babies born to ‘O’ positive mothers: A prospective cohort studyKathmandu University Medical Journal, 1970